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Summary
Dedicator of cytokinesis (DOCK) proteins are guanine nucle-
otide exchange factors (GEFs) controlling the activity of
Rac1/Cdc42 during migration, phagocytosis, and myoblast
fusion [1–4]. Engulfment and cell motility (ELMO) proteins
bind a subset of DOCKmembers and are emerging as critical
regulators of Rac signaling [5–10]. Although formation of
a DOCK180/ELMO complex is not essential for Rac1 activa-
tion, ELMO mutants deficient in binding to DOCK180 are
unable to promote cytoskeleton remodeling [11]. How
ELMO regulates signaling through DOCK GEFs is poorly
understood. Here, we identify an autoinhibitory switch in
ELMO presenting homology to a regulatory unit described
for Dia formins. One part of the switch, composed of
a Ras-binding domain (RBD) and Armadillo repeats, is
positioned N-terminally while the other is housed in the
C terminus. We demonstrate interaction between these frag-
ments, suggesting autoinhibition of ELMO. Using a biolumi-
nescence resonance energy transfer biosensor, we estab-
lish that ELMO undergoes conformational changes upon
disruption of autoinhibition. We found that engagement of
ELMO to RhoG, or with DOCK180, promotes the relief of
autoinhibition in ELMO. Functionally, we found that ELMO
mutants with impaired autoregulatory activity promote
cell elongation. These results demonstrate an unsuspected
level of regulation for Rac1 signaling via autoinhibition of
ELMO.
Results and Discussion
The guanine nucleotide exchange factor (GEF) activity of dedi-
cator of cytokinesis (DOCK) proteins is mediated by the DOCK
homology region 2, a module exclusive to this family of GEFs
[5, 12–14]. The identification of upstream regulators of the
DOCK180-Rac pathway revealed a role for this GEF in devel-
opmental and pathological processes [2, 15–18]. Previous
studies demonstrated a total requirement for engulfment and
cell motility (ELMO) proteins in biological processes controlled
by DOCK180 [1, 11]. Nevertheless, the molecular mechanisms*Correspondence: jean-francois.cote@ircm.qc.ca
6These authors contributed equally to this workby which ELMO orchestrates Rac signaling in concert with
DOCK180 remain to be established. We used bioinformatics
to search for novel structural elements in ELMO that could
regulate Rac signaling. Threading analysis performed with
the Phyre algorithm identified Armadillo repeats (ARR) in
ELMO1–3 and Drosophila ELMO bearing structural homology
to ARR found in the formin Dia1 [19] (see Figure S1A available
online). Structural homology between ELMO1 and the formins
Dia1 [20, 21] and FHOD1 [22] was also detected with the 3D-
Jury structure prediction algorithm (Figure S1B). Finally,
BLAST searches uncovered primary amino acid sequence
similarity between ELMO1 and FHOD1 (Figure S1C). The
region in Dia1 and FHOD1 sharing homology to ELMO is the
diaphanous inhibitory domain (DID) and is characterized to
engage in intramolecular interactions with a diaphanous
autoregulatory domain (DAD) to maintain these proteins in a
repressed state [23]. A hallmark of this regulatory switch is
the presence of a GTPase-binding site N-terminal to the DID.
Mechanistically, engagement of GTPases to autoinhibited
formins disrupts the inhibitory DID-DAD interactions, thereby
exposing their actin polymerization activity [20, 22]. Because
the region in ELMO preceding the ARR interacts with RhoG
[8], this led us to hypothesize that the N terminus of ELMO
may constitute part of a similar autoinhibitory module.
We therefore termed the ARR in ELMO as the ELMO inhibitory
domain (EID) (Figure 1A). Based on sequence alignment with
FHOD1, the EID is defined by one HEAT domain followed
by four ARR (Figure 1B). Searching for the equivalent of the
formins’ DAD in ELMO is not straightforward because this
functional region is not a domain but rather a short amphi-
pathic helix. We nevertheless identified a C-terminal region
in ELMO that resembles the formins’ DAD [19, 24], and we
named it the ELMO autoregulatory domain (EAD) (Figures 1A
and 1C).
If the EID and EAD of ELMO behave like the analogous
domains in formins, they should interact directly. We tested
whether ELMO11–315 can interact with ELMO1315–727 and found
that these two ELMO1 fragments specifically coprecipitated
with DOCK180 (Figure 1D). The critical residues of Dia1 and
FHOD1 DIDs involved in binding the DAD, alanine 256 and
valine 228, respectively, are located in a hydrophobic region
of the last helix of the third ARR [19, 22]. Structure-based align-
ment of the ELMO EID with the DIDs of Dia1 and FHOD1 sug-
gested L202, I204, and L205 as candidate residues potentially
important for the function of the ELMO EID. By analyzing the
Phyre -generated 3D model of the ELMO1 EID and comparing
it to the structures of Dia1 and FHOD1, we found I204 to be
surface exposed and thus likely to contribute to EAD binding
(Figure S1D). We found that two mutants in this hydrophobic
patch, ELMO11–315(I204D) and ELMO11–315(L202E/I204D/L205E), lost
the ability to interact with ELMO1315–727 in both coimmunopre-
cipitation and yeast two-hybrid assays (Figures 1D and 1E).
Mutation of another nearby residue in the ELMO1 EID,
Y216F, did not affect the EID/EAD interaction (Figures 1D
and 1E). Next, we investigated which residues in the EAD are
critical in EID binding. To provide evidence that the EAD is
included in the predicted a helix located between amino
acids 681 and 701 of ELMO1 (Figure 1C), we used the yeast
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Figure 1. Intramolecular Interactions in ELMO1 through Novel Domains
(A) Schematic representation of the structural homology between ELMO and Dia-family formins.
(B) The ELMO1 EID domain is composed of HEAT and Armadillo repeats (ARR). Predicted a helices are shown in gray, hydrophobic residues of the ARR
consensus sequence in yellow, and polar residues in blue and red. I204 in ARR-3 (green) is a conserved residue of ELMO proteins.
(C) Sequence alignment of the autoregulatory domains of ELMO (EAD) and Dia-related formins (DAD). Red arrows indicate highly conserved residues form-
ing the core motif.
(D and E) Mutation of critical EID or EAD residues disrupts EID/EAD interaction in coimmunoprecipitation (D) and the yeast two-hybrid system (E).
(D) Lysates of HEK293T cells transfected with the indicated plasmidswere subjected to immunoprecipitation with an anti-FLAG (lanes 1–4) or anti-DOCK180
H-70 (lanes 5–8) antibody. Immunoblots were analyzed with anti-Myc (ELMO1) and anti-DOCK180 (H-70) antibodies. ‘‘HC’’ indicates IgG heavy chain.
(E) Yeasts cotransformed with LexA fusion construct of ELMO11–315 and B42 fusion constructs of ELMO1315–727 were grown on nonselective and selective
(2Leu) media for a nutrient-selective growth assay.
(F) Mapping of critical EAD region boundaries. Yeasts cotransformed with the indicated plasmids were assayed as in (E).
See also Figure S1.
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2022two-hybrid system. We found that nested C-terminal trunca-
tions (ELMO1532–727 and ELMO1532–707) maintained interaction
with ELMO11–315, whereas further deletion of the region con-
taining the predicted EAD (ELMO1532–675) diminished the bind-
ing (Figure 1F). In both FHOD1 and Dia1, the conserved methi-
onine of the DAD is responsible for extensive contacts with theDID [19, 24] (Figure 1C). Therefore, the equivalent methionine
692 and the highly conserved glutamate 693 of ELMO1 were
both mutated to alanine. We found that ELMO11–315 was inca-
pable of binding ELMO1315–727(M692A/E693A) in a yeast two-
hybrid interaction assay, yet this mutant retained the ability
to bind DOCK180 (Figure 1E; Figure S1E). Importantly,
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Figure 2. The N Terminus of ELMO1 Contains a Ras-Binding Domain
(A) Secondary structure and sequence comparison between ELMO-family proteins, FHOD1, and Raf1 indicates an evolutionarily conserved Ras-binding
domain (RBD) characterized by the presence of a ubiquitin-like subdomain. ELMO secondary structure was predicted with Jpred3. FHOD1 (Protein Data
Bank ID code 3DAD) and Raf1 (Protein Data Bank ID code 1GUA) structures were used for the manual alignment with the ELMO RBDs. Residues potentially
involved in contacting RhoG are shown in red. E indicates b strand, H indicates a-helical.
(B and C) L43A mutation in the ELMO1 RBD abolishes the interaction with RhoGV12.
(B) GST-tagged versions of the indicated ELMO1proteinswere used to pull downHA-tagged RhoGV12 fromHEK293T lysates. Bound proteins were detected
by immunoblotting with an anti-HA antibody.
(C) Transfected HEK293T cells were subjected to immunoprecipitation against Myc-tagged ELMO1. Bound proteins were analyzed by immunoblotting with
anti-HA (RhoGV12) and anti-Myc (ELMO1) antibodies.
(D) Mutational inactivation or deletion of the ELMO1 RBD results in defective cell elongation. Left: images show overlay of anti-H-4 (DOCK180), rhodamine
phalloidin, and DAPI stains. Scale bar represents 10 mm. Right: several independent fields of the experiments were scored for the indicated phenotypes.
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2023mutation of other residues in this region, namely R697A/
L698A/L699A, had no effect on the EID/EAD interaction
(Figures 1D and 1E).
The presence of GTPase-binding activity at the N terminus
of ELMO proteins [8] suggests that the EID/EAD interactions
could be regulated by engagement of active RhoG in a model
suggestive of Dia-family formin activation [23]. Despite simi-
larity in their DIDs, the GTPase-binding domains of Dia1 and
FHOD1 are structurally unrelated [25]. In Dia1, this domain is
solely a-helical and Rho selective, whereas in FHOD1, it is
composed of a ubiquitin fold found in Ras-binding domains
(RBDs) and is Rac specific [20, 22]. Our bioinformatic analyses
uncovered that the GTPase-binding boundary of ELMO pro-
teins belongs to the family of RBDs [26]. We found homology
between ELMO, FHOD1, and c-Raf RBDs. Superimposition
of FHOD1 and c-Raf RBD structures results in the alignment
with ELMO shown in Figure 2A. This data allowed us to narrow
in on leucine 43 as a likely candidate in the ELMO1 RBD
to mediate contact to active RhoG on the basis that the
analogous residue in c-Raf is in contact with Ras [26]. In GST
pull-down assays, both ELMO1L43A and ELMO11–315(L43A)
were incapable of binding RhoGV12 (Figure 2B). Similarly,
ELMO11–315(L43A) was impaired in RhoGV12 binding in coimmu-
noprecipitation assays (Figure 2C). Functionally, we found thatELMO1 mutants lacking RBD activity failed to synergize with
DOCK180 and CrkII in promoting cell elongation (Figure 2D),
suggesting that this domain is essential for the biological
activity of the complex.
Although ELMO associates with RhoG [8], the minimal pro-
tein surface responsible for the interaction is poorly character-
ized. We investigated whether the RBD of ELMO is sufficient
for membrane targeting by RhoG. We found that both the RBD
(Myc-ELMO11–113) and the RBD-EID unit (Myc-ELMO11–315),
but not the L43Amutant counterparts, relocalized to the mem-
branewhencoexpressedwithRhoGV12 (Figure 3A; FigureS2A).
ELMO1 lacking the RBD, ELMO1113–727, also failed to relocal-
ize to the membrane when coexpressed with RhoGV12 (Fig-
ure 3A). These results support the hypothesis that engage-
ment of the RBD of ELMO proteins to GTPases may be a key
event to localize and anchor the ELMO/DOCK complex at
the membrane. To test whether the engagement of active
RhoG to the RBD competes with the EID/EAD interaction,
we performed a biochemical cell fractionation assay. We
observed that, as expected, the RBD-EID unit of ELMO
(Myc-ELMO11–315) was enriched in the membrane fraction
when expressed with RhoGV12 (Figures 3B and 3C). Coexpres-
sion of an ELMO fragment containing the EAD (Myc-
ELMO1315–727) in this system coerced the RBD-EID fragment
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Figure 3. Full-Length ELMO2 Is Autoinhibited and Regulated by RhoG Binding to the RBD
(A) Membrane recruitment of the ELMO1 RBD by RhoG. HeLa cells were transfected with the indicated plasmids, and ELMO1 and RhoGV12 localization was
analyzed with anti-Myc and anti-HA antibodies, respectively. Scale bar represents 20 mm.
(B and C) In the presence of RhoGV12, the ELMO1 EAD-containing fragment coerces ELMO1 RBD-EID away from the membrane and into the cytosol.
(B) HEK293T cells were transfected with the indicated plasmids, and cytosolic andmembrane fractions were biochemically purified and analyzed via immu-
noblotting with the indicated antibodies.
(C) Quantification of band intensity was used to calculate the ratio of protein found in the membrane versus the cytosol. Error bars represent standard devi-
ation; n = 3.
(D) Disrupting the EID/EAD interaction leads to conformational changes in ELMO2. Top: schematic model of the GFP10-ELMO2-RlucII conformation
biosensor. Bottom: luminescence at 400 nm and 510 nm was measured upon addition of DeepBlueC in HEK293T cells expressing the indicated proteins.
Analysis of variance and Bonferroni’s multiple comparison were performed to compare each condition. ***p < 0.001; error bars represent standard error of
the mean; n = 3.
See also Figure S2.
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2024away from RhoGV12 at the membrane, increasing the propor-
tion of Myc-ELMO11–315 in the cytosol (Figures 3B and 3C).
To address whether intramolecular interactions would take
place in full-length ELMO, we developed a bioluminescence
resonance energy transfer (BRET2) ELMO conformation
biosensor. We tagged ELMO2 at its extremities with GFP10
and Renilla luciferase (RlucII) tags (Figure 3D). ELMO2 was
chosen because it is compatible for cloning in the BRET2
vector and shares 88% similarity with ELMO1. Because
our model predicts spatial proximity between the N- and
C-terminal ends of ELMO proteins, the BRET2 signal should
occur in the autoinhibited state and decrease in the active
conformation. Indeed, BRET2 signal was detected when
GFP10-ELMO2-RlucII was expressed alone (Figure 3D). Impor-
tantly, the BRET2 signal observed was independent of the
concentration of ELMO2, indicating that intramolecularinteractions instead of oligomerization events were being
observed (Figure S2B). To test whether disturbing the EID/
EAD interaction in ELMO2 leads to conformational changes,
we expressed GFP10-ELMO2-RlucII with function-inactivating
mutations in the EID (I196D or L194E/I196D/L197E); we
detected a decrease in BRET2 signal, suggesting that these
mutants are in an open conformation (Figure 3D). Mutation of
residue L43A in the RBD did not affect BRET2 signal (Fig-
ure 3D). We used this probe to test whether interaction of
ELMO2 with its binding partners RhoGV12 and DOCK180 could
affect the conformation state of ELMO2. Unfortunately, the
bulky tags on the GFP10-ELMO2-RlucII almost totally abol-
ished the interaction with RhoGV12 (Figure S2C), preventing
us from conclusively determining whether this GTPase can
alter ELMO2 conformation in this assay. Interestingly, the
binding of DOCK180 to GFP10-ELMO2-RlucII, which still
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Figure 4. The EID/EAD Intramolecular Interaction Is a Regulatory Feature of ELMO in Cells
(A) Activated ELMO1 mutants synergize with RhoG to promote cell elongation. HeLa cells were transfected with the indicated plasmids, and ELMO1 and
RhoGV12 localization was observed with anti-Myc and anti-HA antibodies, respectively. Scale bar represents 20 mm.
(B) Quantification of the effect of ELMO1mutations on cell elongation. Themorphology of cells in (A) was analyzedwith anti-Myc antibodies. For each condi-
tion, the Feret’s diameter of >40 cells was measured (bars represents lowest and highest values; see Supplemental Experimental Procedures).
(C) Activated ELMO1 mutants promote cell elongation on fibronectin. Serum-starved LR73 cells transfected with the indicated ELMO1 plasmids were
detached and plated on fibronectin-coated chambers for 2 hr. Cells were stained for ELMO1 (anti-Myc) and DOCK180 (H-70). Scale bar represents 20 mm.
(D) Quantification of cell morphology (see Supplemental Experimental Procedures). For each condition, >100 cells were analyzed. In (B) and (D), analysis of
variance and Bonferroni’s multiple comparison were performed to compare each condition. *p < 0.05, **p < 0.005, ***p < 0.001; error bars represent standard
error of the mean; n = 3.
See also Figure S3.
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2025occurred, promoted conformational changes in ELMO2, sug-
gesting that DOCK180 can participate in promoting the open
conformation of ELMO (Figures S2D and S2E).
A previous report highlighted that ELMO can induce stress
fibers [10], whereas other studies noted that ELMO has no
effect on the cytoskeleton [6, 7, 11, 27]. We reasoned that if
ELMO autoinhibition is important for regulating Rac signaling,
activated mutants of ELMO1 should promote cytoskeletal
changes. We studied the impact of ELMO1 in the presence
and absence of RhoGV12 on the morphology of HeLa cells
grown on poly-L-lysine. Expression of ELMO1WT, ELMO1I204D,
ELMO1M692A/E693A, or ELMO1L43A did not induce morpholog-
ical alteration in comparison to control cells (Figure S3A).
In contrast, expression of RhoGV12 amplified cell spreading as
judged by morphology and quantification of the Feret’sdiameter (Figures 4A and 4B). When RhoGV12 was coex-
pressed with ELMO1WT and ELMO1L43A, membrane ruffles
additionally characterized the cells, but notably, their Feret’s
diameters were unchanged with respect to cells expressing
RhoGV12 (Figures 4A and 4B). Strikingly, the active ELMO
mutants ELMO1I204D and ELMO1M692A/E693A distinctly pro-
moted cell elongation when expressed with RhoGV12 (Figures
4A and 4B). We next analyzed the morphology of integrin-acti-
vated HeLa cells expressing ELMO1 and found that ELMO1WT
and ELMO1L43A failed to induce cytoskeletal changes (Figures
4C and 4D). In agreement with our data suggesting a central
role for the RBD in localizing ELMO at the membrane during
integrin signaling, we noted that ELMO1L43A remained cyto-
solic (Figure 4C). Notably, ELMO1mutants lacking autoregula-
tory properties (ELMO1I204D and ELMO1M692A/E693A) efficiently
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2026accumulated at cell extremities and induced cell elongation
(Figures 4C and 4D). We found that control mutants in which
the EID/EAD interaction was not abrogated, ELMO1Y216F and
ELMO1R697A/L698A/L699A, behaved like ELMO1WT (Figures 4C
and 4D). Furthermore, we found that constitutively activated
ELMO1 variants (ELMO1I204D and ELMO1M692A/E693A) were
sufficient to induce a more than 2-fold increase in cell motility
(Figure S3B). Significantly, uncoupling DOCK180 binding from
these constitutively activated ELMO1 mutants abrogated the
cell elongation phenotype, indicating that they are dependent
on DOCK180-mediated activation of Rac (Figure S3C). Finally,
we observed little impact on global Rac activation in either
293T or LR73 cells expressing active ELMO1 mutants (Fig-
ure S3D). Instead, we found that these mutants promote
cell elongation by localizing DOCK180 at the membrane
(Figure 4C).
In this study, we identified three novel domains in ELMO
proteins: the RBD, EID, and EAD. We propose that the activa-
tion state of ELMO proteins is regulated, much like in Dia-
family formins, via interaction with other proteins.We provided
biochemical evidence that active RhoG and the ELMO EAD
compete for binding to the ELMO RBD-EID unit, suggesting
that RhoG could actively participate in unleashing the EID/
EAD negative regulation. However, we cannot rule out the
alternative hypothesis that RhoG recruits ‘‘inactive’’ ELMO to
the membrane, where an additional interaction partner comes
into play to stabilize ELMO in an active conformation. We also
found that DOCK180 binding to ELMO promotes conforma-
tional changes in ELMO. This result is in agreement with
several reports suggesting that coexpression of ELMO and
DOCK180 is essential for optimal activity of the complex,
and we now propose that this may be a consequence of
favoring the open conformation of ELMO.
The physiological relevance of the RhoG/ELMO/DOCK180
interaction is not clear. In fact, new lines of evidence suggest
that RhoG may contribute modestly to the regulation of this
pathway. First, whereas DOCK180 mutant mice suffer from
defects in myoblast fusion [4], mice lacking RhoG undergo
normal development [28], suggesting that this GTPase cannot
be amaster regulator of DOCK180 signaling. Second, although
RhoG is a bona fide ELMObinder, it is not activated by integrin
engagement and is not an essential upstream component of
DOCK180 in cell spreading [29]. Here, we demonstrated that
ELMO recruitment at the membrane is dependent on the
activity of the RBD during integrin signaling, suggesting that
one or more additional GTPases, activated by integrins, must
bind ELMO. The exact mechanism whereby open ELMO
mutants are able to promote polarity is not understood. Our
model is that ELMO may enter a repressed state to mask an
intrinsic enzymatic activity much like formins do to control
their actin nucleation potential. The central region of ELMO
contains an uncharacterized ELM domain suspected to house
GAP activity toward Arf GTPases [30]. Our structure/function
analysis suggests that the ELM is essential for the polarization
activity of the ELMO/DOCK180 complex (data not shown). We
are currently testing whether the ELM carries GAP enzymatic
activity and, more importantly, whether the autoinhibitory
switch regulates it.Supplemental Information
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